Vilela Fernanda Aguiar Santos, Carneiro Sueli, Ramos-e-Silva Marcia
Sector of Dermatology, University Hospital and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
J Drugs Dermatol. 2010 Oct;9(10):1213-9.
Scleroderma is a disease that affects the microvasculature and the connective tissue. These alterations produce fibrosis and blood vessel occlusion. Its cause is still unknown, although the exaggerated synthesis of collagens I and IV, detected in skin and vessels, may be related to genetic, immunologic and, less frequently, exogenous factors as inhalation of silica and polyvinyl chloride. There is a localized and a systemic form, which affects both adults and children. The treatment of the localized form, also called morphea, is still controversial, and, in this article, the authors will discuss the main agents that were found to improve the lesions and symptoms.
硬皮病是一种影响微血管和结缔组织的疾病。这些改变会导致纤维化和血管闭塞。其病因尚不清楚,尽管在皮肤和血管中检测到的I型和IV型胶原蛋白过度合成可能与遗传、免疫因素有关,较少情况下也与外源性因素如吸入二氧化硅和聚氯乙烯有关。硬皮病有局限性和系统性两种形式,可影响成人和儿童。局限性硬皮病(也称为硬斑病)的治疗仍存在争议,在本文中,作者将讨论已发现的可改善病变和症状的主要药物。